Attempted Suicide With Acetaminophen Among 8-18 Year-old Children / Adolescents in Denmark
1 other identifier
observational
500
1 country
1
Brief Summary
A: Early predictors of hepatic injury after suicide attempt with acetaminophen: To explore the following in a pediatric population with acetaminophen overdose due to suicide attempt: 1) the prevalence of episodes of pre- and in-hospital vomiting and the relationship between the total number of vomiting episodes and hepatic injury, 2) the relevance of the early initiation of N-acetylcysteine (NAC) treatment to hepatic injury, and 3) the presence/absence of illness prior to the suicide attempt and hepatic injury. B: Characteristics, social behaviour, trends and risk factors: 1\. To explore the relationship between children admitted to a paediatric department as a result of suicide attempts with acetaminophen and their parents and friends. 2. To determine the extent to which the children had attempted to speak to their parents or other adults about their problems before their suicide attempts. 3. To determine the prevalence of self-mutilation among children with suicidal behaviour. 4. To examine the reasons for these suicide attempts. C: Establishment of the expression of cytochrome P450 in a pediatric including the age-adjusted activities. Urine samples will be analyzed using an HPLC tandem mass spectrometric method, which we have already established in our lab. There will be categorized three groups for comparison:
- 1.An age-appropriate background population (approximately 200 patients)
- 2.Paediatric patients that have been admitted to Rigshospitalet, due to severe hepatic injury (approximately 50 patients)
- 3.Other pediatric patients admitted to their local hospital because of acetaminophen poisoning (approximately 200 patients) A control urine sample will be analyzed three months after the suicide attempt.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 24, 2013
CompletedFirst Posted
Study publicly available on registry
November 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedNovember 11, 2013
November 1, 2013
10.6 years
October 24, 2013
November 5, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Early predictors of hepatic injury
1\) To identify early clinical and biochemical predictors of hepatoxicity in children and adolescents after the ingestion of a single acetaminophen overdose as a part of a suicide attempt e.g. pre-hospital vomiting, in-hospital vomiting, stomach pains, latency time before NAC treatment, illness prior to the suicide attempt. The initial and maximum levels of the following biochemical parameters are registered from the electronic biochemistry files of each patient: gluthathione (GLU), basic phosphatase (BP), INR, ALT, AST, and s-acetaminophen.
2 years
Secondary Outcomes (2)
Expression of CYP 1A2 in a pediatric population
2 years
Characteristics, social behaviour, trends and risk factors
2 years
Eligibility Criteria
Pediatric Department, children/adolescents who have tried to commit suicide with acetaminophen (8-18 years-old)
You may qualify if:
- years-old, who tried to commit suicide with acetaminophen.
- Children are only included if they have answered all our standard questions.
You may not qualify if:
- Children with known liver disease prior to the suicide attempt.
- Suicide attempts with other agents than acetaminophen.
- Children taking medication that enhance the induction of the cytochrome P450 system, increase the production of toxic metabolites, and aggravate the hepatic injury, such as ethanol, rifampin, isoniazid, barbiturates, and carbamazepine, will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nordsjællands Hospital
Hillerød, 3400, Denmark
Biospecimen
The initial and maximum levels of the biochemical parameters will be registered from the electronic biochemistry files of each patient: GLU, basic phosphatase (BP), INR, ALT, and AST.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Target Duration
- 5 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 24, 2013
First Posted
November 11, 2013
Study Start
January 1, 2005
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
November 11, 2013
Record last verified: 2013-11